- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top pharma companies worldwide by number of originated drugs 2019
Top pharma companies worldwide by number of originated drugs 2019
Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*
This statistic shows the top 10 pharmaceutical companies worldwide in 2019, by projected number of originated drugs. For that year, projections said there will be 131 such drugs from Swiss-based company Novartis.
Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*
Loading statistic...
| Number of originated drugs | |
|---|---|
| Novartis | 131 |
| Johnson & Johnson | 112 |
| AstraZeneca | 111 |
| Roche | 106 |
| GlaxoSmithKline | 99 |
| Takeda | 99 |
| Pfizer | 96 |
| Sanofi | 93 |
| Merck & Co. | 86 |
| Bayer | 77 |
| Number of originated drugs | |
|---|---|
| Novartis | 131 |
| Johnson & Johnson | 112 |
| AstraZeneca | 111 |
| Roche | 106 |
| GlaxoSmithKline | 99 |
| Takeda | 99 |
| Pfizer | 96 |
| Sanofi | 93 |
| Merck & Co. | 86 |
| Bayer | 77 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the top 10 pharmaceutical companies worldwide in 2019, by projected number of originated drugs. For that year, projections said there will be 131 such drugs from Swiss-based company Novartis.
Show more- Show sources information
- Show publisher information
- Release date
- March 2019
- Region
- Worldwide
- Survey time period
- as of January 2019
- Supplementary notes
- * Projected as of January 2019.
Source
- Show sources information
- Show publisher information
- Release date
- March 2019
More information
- Region
- Worldwide
- Survey time period
- as of January 2019
- Supplementary notes
- * Projected as of January 2019.
Other statistics on the topic
Pfizer
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Eli Lilly
- 49 page/s
- English
- pptx
- Detailed references
Everything On "Eli Lilly" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Eli Lilly"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2018
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Global top 10 companies based on biotech prescription drug market share in 2017 and 2024*Global biotech prescription drug market share - top 10 companies 2017 and 2024
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*Top pharma companies worldwide by number of originated drugs 2019
- Top 10 pharmaceutical companies by global anti-diabetic revenue in 2017 and 2024 (in million U.S. dollars)Global anti-diabetic revenue by top ten pharmaceutical companies 2017 and 2024
- Top 20 pharmaceutical companies based on R&D spending as revenue share in 2017 and 2024*R&D spending share of top pharmaceutical companies 2017 and 2024
- Revenue and income
The most important statistics
- Revenue of Eli Lilly and Company from 2007 to 2018 (in million U.S. dollars)Eli Lilly's total revenue 2007-2018
- Revenue of Eli Lilly and Company from 2014 to 2018, by segment (in million U.S. dollars)Eli Lilly's total revenue by segment 2014-2018
- Revenue of Eli Lilly and Company from 2014 to 2018, by region (in million U.S. dollars)*Eli Lilly's total revenue by region 2014-2018
- Eli Lilly and Company's top products based on revenue from 2014 to 2018 (in million U.S. dollars)Eli Lilly and Company's top products based on revenue 2014-2018
- Net income of Eli Lilly and Company from 2007 to 2018 (in million U.S. dollars)Eli Lilly's net income 2007-2018
- Eli Lilly's income before income taxes from 2013 to 2018 (in million U.S. dollars)Eli Lilly income before income taxes 2013-2018
- Expenses
The most important statistics
- Eli Lilly and Company's expenditure on research and development from 2007 to 2018 (in million U.S. dollars)Eli Lilly's research and development expenditure 2007-2018
- Eli Lilly's marketing, selling, and administrative expenses from 2013 to 2018 (in million U.S. dollars)Eli Lilly: marketing expenses 2013-2018
- Eli Lilly's capital expenditures from 2013 to 2018 (in million U.S. dollars)Eli Lilly capital expenditures 2013-2018
- Eli Lilly and Company advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)Eli Lilly: ad spend in the U.S. 2012-2017
- Miscellaneous
The most important statistics
- Eli Lilly's number of employees from 2013 to 2018Eli Lilly employment numbers 2013-2018
- Revenue per employee of Eli Lilly and Company from 2013 to 2018 (in U.S. dollars)Eli Lilly's total revenue per employee 2013-2018
- Eli Lilly's total assets from 2013 to 2018 (in million U.S. dollars)Eli Lilly total assets 2013-2018
- Eli Lilly and Company's spending for research and development as a share of revenue from 2010 to 2018*Eli Lilly's R&D expenditure as a share of revenue 2010-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. number of venture capital deals for neurology companies 2006-2017
- U.S. venture investments in infectious disease companies from 2006 to 2017
- Market cap of select pharma companies with strong pipeline 2017
- Multiple sclerosis management products in development in the U.S. 2014
- U.S. psychiatry company IPO financing 2006-2017
- U.S. number of IPOs for neurology companies 2006-2017
- Trust in pharmaceutical companies worldwide by clinical trial knowledge 2017
- U.S. number of venture capital deals for infectious disease companies 2006-2017
- Projected top pharmaceutical companies based on new sales 2018-2019
- U.S. infectious disease company IPOs 2006-2017
- U.S. cardiovascular company IPOs 2006-2017
- U.S. venture funding of therapeutic companies by disease type 2017
- Top approved MS therapies in the U.S. by ARR 2014
- Projection of top 10 global pharmaceutical companies by revenue 2019
- Revenue of top growing private specialty pharmacies in U.S. 2017
- Worldwide generic pharmaceutical M&A deal value 2007-2015
- Manufacturer prices for brand name prescription drugs in the U.S.
- Italy: trend of consumption of dermatological drugs 2011-2017
- Causes of drug shortages in the U.S. 2011-2013
- Astellas Pharma's female employee rate FY 2014-2017
Studies
- Pharmaceutical trends in Europe
- Indicatori Farmaceutici
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Pharmaceutical industry in the Netherlands
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
- The 2018 Genentech Oncology Trend Report
- PAGB Annual Review 2017-2018
- Generic Pharmaceutical Industry Yearbook 2016
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Services
- Antibiotic use in the United Kingdom (UK)
- Teva - 2018 Form 10-K
- Biotechnology in Germany
- 2018 PhRMA Annual Membership Survey
Statistics on "Eli Lilly"
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Global top 10 companies based on biotech prescription drug market share in 2017 and 2024*
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*
- Top 10 pharmaceutical companies by global anti-diabetic revenue in 2017 and 2024 (in million U.S. dollars)
- Top 20 pharmaceutical companies based on R&D spending as revenue share in 2017 and 2024*
- Revenue of Eli Lilly and Company from 2007 to 2018 (in million U.S. dollars)
- Revenue of Eli Lilly and Company from 2014 to 2018, by segment (in million U.S. dollars)
- Revenue of Eli Lilly and Company from 2014 to 2018, by region (in million U.S. dollars)*
- Eli Lilly and Company's top products based on revenue from 2014 to 2018 (in million U.S. dollars)
- Net income of Eli Lilly and Company from 2007 to 2018 (in million U.S. dollars)
- Eli Lilly's income before income taxes from 2013 to 2018 (in million U.S. dollars)
- Eli Lilly and Company's expenditure on research and development from 2007 to 2018 (in million U.S. dollars)
- Eli Lilly's marketing, selling, and administrative expenses from 2013 to 2018 (in million U.S. dollars)
- Eli Lilly's capital expenditures from 2013 to 2018 (in million U.S. dollars)
- Eli Lilly and Company advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)
- Eli Lilly's number of employees from 2013 to 2018
- Revenue per employee of Eli Lilly and Company from 2013 to 2018 (in U.S. dollars)
- Eli Lilly's total assets from 2013 to 2018 (in million U.S. dollars)
- Eli Lilly and Company's spending for research and development as a share of revenue from 2010 to 2018*
- Number of venture capital deals for neurology companies in the U.S. from 2006 to 2017
- Venture investments in infectious disease companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
- Market capitalization of select therapeutic pharmaceutical companies as of 2017 (in billion U.S. dollars)*
- Number of multiple sclerosis drugs in development in the United States as of July 2014
- Amount raised through initial public offerings (IPOs) from psychiatry companies in the U.S. from 2006 to 2017 (in million U.S. dollars)*
- Number of initial public offerings (IPOs) for neurology companies in the U.S. from 2006 to 2017*
- Percentage of adults that trust pharmaceutical companies to release accurate information about new medicines as of 2017, by clinical trial knowledge
- Number of venture capital deals for infectious disease companies in the U.S. from 2006 to 2017
- Top pharmaceutical companies in 2019 based on sales increase over 2018 (in billion U.S. dollars)
- Number of initial public offerings (IPOs) from companies in infectious disease in the U.S. from 2006 to 2017*
- Number of initial public offerings (IPOs) from cardiovascular companies in the U.S. from 2006 to 2017*
- Venture funding of U.S. therapeutic companies in 2017, by disease type (in million U.S. dollars)
- Selected approved multiple sclerosis therapies as of 2014, ranked by ARR*
- Projected top 10 pharmaceutical companies worldwide by revenue in 2019 (in billion U.S. dollars)*
- Fastest-growing private specialty pharmacies in the U.S. in 2017, by revenue (in million U.S. dollars)
- Value of generic pharmaceutical merger and acquisition deals worldwide from 2007 to 2015 (in billion U.S. dollars)
- Average annual percent change in manufacturer prices for widely used brand name prescription drugs in the U.S. 2002-2010
- Trend of consumption of dermatological drugs in Italy from 2011 to 2017 (in DDD* per 1,000 inhabitants per day)
- Reported causes of drug shortages in the United States between January 2011 and June 2013
- Rate of female employees working for Astellas Pharma Inc. from fiscal year 2014 to 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.